Researchers are a step closer to transforming a US$70 billion global diagnostic industry with new designer biosensors that ‘switch on’ colour or electrical responses to drugs used in cancer, arthritis ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback